Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Brain Informatics|March 3, 2023
Measuring cognitive load of digital interface combining event-related potential and BubbleViewShaoyu Wei, Ruiling Zheng, Rui Li, et al.
Frontiers in Chemistry|October 21, 2022
Nanoengineered, magnetically guided drug delivery for tumors: A developmental studyTieyu Chen, Yanyu Kou, Ruiling Zheng, et al.
European Journal of Pharmacology|August 4, 2023
C1632 inhibits ovarian cancer cell growth and migration by inhibiting LIN28 B/let-7/FAK signaling pathway and FAK phosphorylationQian Zhang, Mengyun Shi, Ruiling Zheng, et al.
Polymers|July 13, 2024
Metal-Organic Framework-Derived Co<sub>9</sub>S<sub>8</sub> Nanowall Array Embellished Polypropylene Separator for Dendrite-Free Lithium Metal AnodesDeshi Feng, Ruiling Zheng, Li Qiao, et al.
International Journal of Biological Macromolecules|June 13, 2022
G-quadruplex stabilizer Tetra-Pt(bpy) disrupts telomere maintenance and impairs FAK-mediated migration of telomerase-positive cellsZhe Shen, Ruiling Zheng, Huamao Yang, et al.
Genes & Diseases|August 17, 2023
A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axisYanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Genes & Diseases|January 31, 2024
Corrigendum to "A novel FGFR1 inhibitor CYY292 suppresses tumor progression, invasion, and metastasis of glioblastoma by inhibiting the Akt/GSK3β/snail signaling axis" [Genes & Diseases 11 (2024) 479-494]Yanran Bi, Ruiling Zheng, Jiahao Hu, et al.
Chemico-Biological Interactions|September 28, 2022
cyy260 suppresses the proliferation, migration and tumor growth of osteosarcoma by targeting PDGFR-β signaling pathwayYinda Qiu, Hao Yan, Ruiling Zheng, et al.
Pageof 1